193 related articles for article (PubMed ID: 12095564)
1. Limitations of conventional doses of chemoradiation for unresectable biliary cancer.
Crane CH; Macdonald KO; Vauthey JN; Yehuda P; Brown T; Curley S; Wong A; Delclos M; Charnsangavej C; Janjan NA
Int J Radiat Oncol Biol Phys; 2002 Jul; 53(4):969-74. PubMed ID: 12095564
[TBL] [Abstract][Full Text] [Related]
2. Radiotherapy or Chemoradiation in Unresectable Biliary Cancer: A Retrospective Study.
Bisello S; Buwenge M; Palloni A; Autorino R; Cellini F; Macchia G; Deodato F; Cilla S; Brandi G; Tagliaferri L; Cammelli S; Valentini V; Morganti AG; Mattiucci GC
Anticancer Res; 2019 Jun; 39(6):3095-3100. PubMed ID: 31177154
[TBL] [Abstract][Full Text] [Related]
3. Is the therapeutic index better with gemcitabine-based chemoradiation than with 5-fluorouracil-based chemoradiation in locally advanced pancreatic cancer?
Crane CH; Abbruzzese JL; Evans DB; Wolff RA; Ballo MT; Delclos M; Milas L; Mason K; Charnsangavej C; Pisters PW; Lee JE; Lenzi R; Vauthey JN; Wong AB; Phan T; Nguyen Q; Janjan NA
Int J Radiat Oncol Biol Phys; 2002 Apr; 52(5):1293-302. PubMed ID: 11955742
[TBL] [Abstract][Full Text] [Related]
4. [Conformal therapy of locally advanced cholangiocarcinoma of the main bile ducts].
Bouras N; Caudry M; Saric J; Bonnel C; Rullier E; Trouette R; Demeaux H; Maire JP
Cancer Radiother; 2002 Feb; 6(1):22-9. PubMed ID: 11899677
[TBL] [Abstract][Full Text] [Related]
5. Stereotactic body radiotherapy in the management of oligometastatic and recurrent biliary tract cancer: single-institution analysis of outcome and toxicity.
Franzese C; Bonu ML; Comito T; Clerici E; Loi M; Navarria P; Franceschini D; Pressiani T; Rimassa L; Scorsetti M
J Cancer Res Clin Oncol; 2020 Sep; 146(9):2289-2297. PubMed ID: 32524292
[TBL] [Abstract][Full Text] [Related]
6. Ablative Radiotherapy Doses Lead to a Substantial Prolongation of Survival in Patients With Inoperable Intrahepatic Cholangiocarcinoma: A Retrospective Dose Response Analysis.
Tao R; Krishnan S; Bhosale PR; Javle MM; Aloia TA; Shroff RT; Kaseb AO; Bishop AJ; Swanick CW; Koay EJ; Thames HD; Hong TS; Das P; Crane CH
J Clin Oncol; 2016 Jan; 34(3):219-26. PubMed ID: 26503201
[TBL] [Abstract][Full Text] [Related]
7. Phase II trial of high-dose conformal radiation therapy with concurrent hepatic artery floxuridine for unresectable intrahepatic malignancies.
Ben-Josef E; Normolle D; Ensminger WD; Walker S; Tatro D; Ten Haken RK; Knol J; Dawson LA; Pan C; Lawrence TS
J Clin Oncol; 2005 Dec; 23(34):8739-47. PubMed ID: 16314634
[TBL] [Abstract][Full Text] [Related]
8. Preoperative hyperfractionated chemoradiation for locally recurrent rectal cancer in patients previously irradiated to the pelvis: A multicentric phase II study.
Valentini V; Morganti AG; Gambacorta MA; Mohiuddin M; Doglietto GB; Coco C; De Paoli A; Rossi C; Di Russo A; Valvo F; Bolzicco G; Dalla Palma M;
Int J Radiat Oncol Biol Phys; 2006 Mar; 64(4):1129-39. PubMed ID: 16414206
[TBL] [Abstract][Full Text] [Related]
9. Adjuvant radio-chemotherapy for extrahepatic biliary tract cancers.
Bonet Beltrán M; Roth AD; Mentha G; Allal AS
BMC Cancer; 2011 Jun; 11():267. PubMed ID: 21702920
[TBL] [Abstract][Full Text] [Related]
10. Dose escalation of radiotherapy in unresectable extrahepatic cholangiocarcinoma.
Elganainy D; Holliday EB; Taniguchi CM; Smith GL; Shroff R; Javle M; Raghav K; Kaseb A; Aloia TA; Vauthey JN; Tzeng CD; Herman JM; Koong AC; Krishnan SX; Minsky BD; Crane CH; Das P; Koay EJ
Cancer Med; 2018 Oct; 7(10):4880-4892. PubMed ID: 30152073
[TBL] [Abstract][Full Text] [Related]
11. Radiochemotherapy with Gemcitabine in Unresectable Extrahepatic Cholangiocarcinoma: Long-term Results of a Phase II Study.
Autorino R; Mattiucci GC; Ardito F; Balducci M; Deodato F; Macchia G; Mantini G; Perri V; Tringali A; Gambacorta MA; Tagliaferri L; Giuliante F; Morganti AG; Valentini V
Anticancer Res; 2016 Feb; 36(2):737-40. PubMed ID: 26851032
[TBL] [Abstract][Full Text] [Related]
12. Hypofractionated Radiation Therapy for Unresectable/Locally Recurrent Intrahepatic Cholangiocarcinoma.
Smart AC; Goyal L; Horick N; Petkovska N; Zhu AX; Ferrone CR; Tanabe KK; Allen JN; Drapek LC; Qadan M; Murphy JE; Eyler CE; Ryan DP; Hong TS; Wo JY
Ann Surg Oncol; 2020 Apr; 27(4):1122-1129. PubMed ID: 31873931
[TBL] [Abstract][Full Text] [Related]
13. Clinical outcomes and toxicity of proton beam therapy for advanced cholangiocarcinoma.
Makita C; Nakamura T; Takada A; Takayama K; Suzuki M; Ishikawa Y; Azami Y; Kato T; Tsukiyama I; Kikuchi Y; Hareyama M; Murakami M; Fuwa N; Hata M; Inoue T
Radiat Oncol; 2014 Jan; 9():26. PubMed ID: 24422711
[TBL] [Abstract][Full Text] [Related]
14. T4 rectal cancer treated with preoperative chemoradiation to the posterior pelvis followed by multivisceral resection: patterns of failure and limitations of treatment.
Sanfilippo NJ; Crane CH; Skibber J; Feig B; Abbruzzese JL; Curley S; Vauthey JN; Ellis LM; Hoff P; Wolff RA; Brown TD; Cleary K; Wong A; Phan T; Janjan NA
Int J Radiat Oncol Biol Phys; 2001 Sep; 51(1):176-83. PubMed ID: 11516868
[TBL] [Abstract][Full Text] [Related]
15. Molecular chemotherapy combined with radiation therapy enhances killing of cholangiocarcinoma cells in vitro and in vivo.
Pederson LC; Buchsbaum DJ; Vickers SM; Kancharla SR; Mayo MS; Curiel DT; Stackhouse MA
Cancer Res; 1997 Oct; 57(19):4325-32. PubMed ID: 9331094
[TBL] [Abstract][Full Text] [Related]
16. Chemoradiation and brachytherapy in biliary tract carcinoma: long-term results.
Deodato F; Clemente G; Mattiucci GC; Macchia G; Costamagna G; Giuliante F; Smaniotto D; Luzi S; Valentini V; Mutignani M; Nuzzo G; Cellini N; Morganti AG
Int J Radiat Oncol Biol Phys; 2006 Feb; 64(2):483-8. PubMed ID: 16242254
[TBL] [Abstract][Full Text] [Related]
17. Radiation dose considerations in the palliative treatment of locally advanced adenocarcinoma of the pancreas.
Wong AA; Delclos ME; Wolff RA; Evans DB; Abbruzzese JL; Tamm EP; Xiong HQ; Ho L; Crane CH;
Am J Clin Oncol; 2005 Jun; 28(3):227-33. PubMed ID: 15923793
[TBL] [Abstract][Full Text] [Related]
18. A phase I trial of hepatic arterial bromodeoxyuridine and conformal radiation therapy for patients with primary hepatobiliary cancers or colorectal liver metastases.
Robertson JM; McGinn CJ; Walker S; Marx MV; Kessler ML; Ensminger WD; Lawrence TS
Int J Radiat Oncol Biol Phys; 1997 Dec; 39(5):1087-92. PubMed ID: 9392548
[TBL] [Abstract][Full Text] [Related]
19. Long-term results of hepatic artery fluorodeoxyuridine and conformal radiation therapy for primary hepatobiliary cancers.
Robertson JM; Lawrence TS; Andrews JC; Walker S; Kessler ML; Ensminger WD
Int J Radiat Oncol Biol Phys; 1997 Jan; 37(2):325-30. PubMed ID: 9069303
[TBL] [Abstract][Full Text] [Related]
20. External beam radiation therapy with or without concurrent chemotherapy for patients with unresectable locally advanced hilar cholangiocarcinoma.
Chen SC; Chen MH; Li CP; Chen MH; Chang PM; Liu CY; Tzeng CH; Liu YM; Yen SH; Chao Y; Huang PI
Hepatogastroenterology; 2015; 62(137):102-7. PubMed ID: 25911877
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
